Search by Drug Name or NDC
NDC 72266-0133-50 Leflunomide 20 mg/1 Details
Leflunomide 20 mg/1
Leflunomide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Fosun Pharma USA Inc.. The primary component is LEFLUNOMIDE.
Product Information
NDC | 72266-0133 |
---|---|
Product ID | 72266-133_0e7b64bf-41fd-498c-e063-6394a90a8fcb |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | Leflunomide |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Leflunomide |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 20 |
Active Ingredient Units | mg/1 |
Substance Name | LEFLUNOMIDE |
Labeler Name | Fosun Pharma USA Inc. |
Pharmaceutical Class | Antirheumatic Agent [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA077087 |
Listing Certified Through | 2025-12-31 |
Package
NDC 72266-0133-50 (72266013350)
NDC Package Code | 72266-133-50 |
---|---|
Billing NDC | 72266013350 |
Package | 30 TABLET in 1 BOTTLE (72266-133-50) |
Marketing Start Date | 2022-11-16 |
NDC Exclude Flag | N |
Pricing Information | N/A |